Evidence map›Paper›PMID 28369034›Full record

ArticleNature genetics2017

SMARCD2 subunit of SWI/SNF chromatin-remodeling complexes mediates granulopoiesis through a CEBPɛ dependent mechanism.

Pierre Priam, Veneta Krasteva, Philippe Rousseau, Giovanni D'Angelo, Louis Gaboury, Guy Sauvageau, Julie A Lessard

Abstract read
PubMed Publisher
In one paragraph

Article in Nature genetics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 79 citations in OpenAlex.

  1. Article
  2. SMARCD1 and Its Functional Relevance in SWI/SNF and Cancer.International journal of molecular sciences · 2026
    Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Pathogenic GATA2 genetic variants utilize an obligate enhancer mechanism to distort a multilineage differentiation program.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Pierre PriamInstitute for Research in Immunology and Cancer (IRIC), University of Montreal, Montreal, Quebec, Canada.
Veneta KrastevaInstitute for Research in Immunology and Cancer (IRIC), University of Montreal, Montreal, Quebec, Canada.
Philippe RousseauInstitute for Research in Immunology and Cancer (IRIC), University of Montreal, Montreal, Quebec, Canada.
Giovanni D'AngeloDivision of Hematology-Oncology, Maisonneuve-Rosemont Hospital, Montreal, Quebec, Canada.
Louis GabouryInstitute for Research in Immunology and Cancer (IRIC), University of Montreal, Montreal, Quebec, Canada.
Guy SauvageauInstitute for Research in Immunology and Cancer (IRIC), University of Montreal, Montreal, Quebec, Canada.
Julie A LessardInstitute for Research in Immunology and Cancer (IRIC), University of Montreal, Montreal, Quebec, Canada.
Institute for Research in Immunology and Cancer · CAHôpital Maisonneuve-Rosemont · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent studies suggest that individual subunits of chromatin-remodeling complexes produce biologically specific meaning in different cell types through combinatorial assembly. Here we show that granulocyte development requires SMARCD2, a subunit of ATP-dependent SWI/SNF (BAF) chromatin-remodeling complexes. Smarcd2-deficient mice fail to generate functionally mature neutrophils and eosinophils, a phenotype reminiscent of neutrophil-specific granule deficiency (SGD) in humans, for which loss-of-function mutations in CEBPE (encoding CEBPɛ) have been reported. SMARCD2-containing SWI/SNF complexes are necessary for CEBPɛ transcription factor recruitment to the promoter of neutrophilic secondary granule genes and for granulocyte differentiation. The homologous SMARCD1 protein (63% identical at the amino acid level) cannot replace the role of SMARCD2 in granulocyte development. We find that SMARCD2 functional specificity is conferred by its divergent coiled-coil 1 and SWIB domains. Strikingly, both CEBPE and SMARCD2 loss-of-function mutations identified in patients with SGD abolish the interaction with SWI/SNF and thereby secondary granule gene expression, thus providing a molecular basis for this disease.

Indexed as

MutationAnimalsAnimals, NewbornCCAAT-Enhancer-Binding ProteinsChromatinChromatin Assembly and DisassemblyChromosomal Proteins, Non-HistoneGene Expression RegulationGranulocytesHematopoiesisHumansImmunohistochemistryKaplan-Meier EstimateMice, 129 StrainMice, Inbred C57BLMice, KnockoutCCAAT-Enhancer-Binding ProteinsCEBPE protein, humanCebpe protein, mouseChromatinChromosomal Proteins, Non-HistoneMuscle ProteinsSMARCD2 protein, humanSmarcd2 protein, mouseTranscription Factors

Identifiers

PMID28369034
OpenAlexW2604631385

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.